Publication - Advice and guidance
Management of threatened miscarriage and recurrent miscarriage: guidance on use of progesterone
The Progesterone Pathway ensures that women who have had at least one previous miscarriage and present with early pregnancy bleeding are offered vaginal micronised progesterone, where it is clinically indicated, and provides guidance on asymptomatic women with four or more previous miscarriages.
The duration of treatment
Vaginal micronised progesterone treatment can be continued until 16 weeks, as per the NICE guideline. See Annex A.